Lexicon Pharmaceuticals Inc (LXRX)

16.81
0.11 0.66
NASDAQ : Health Care
Prev Close 16.70
Open 16.68
Day Low/High 16.50 / 16.85
52 Wk Low/High 7.65 / 15.84
Volume 144.23K
Avg Volume 779.60K
Exchange NASDAQ
Shares Outstanding 105.24M
Market Cap 1.77B
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Lexicon Collaborator Ipsen Receives Positive CHMP Opinion For Xermelo® (Telotristat Ethyl)

Lexicon Collaborator Ipsen Receives Positive CHMP Opinion For Xermelo® (Telotristat Ethyl)

First -in-Class Oral Tryptophan Hydroxylase Inhibitor to be Considered for Approval in Europe for the Treatment of Carcinoid Syndrome Diarrhea in Combination with Somatostatin Analog Therapy

Interesting LXRX Put And Call Options For August 18th

Investors in Lexicon Pharmaceuticals, Inc. saw new options become available this week, for the August 18th expiration.

Lexicon Pharmaceuticals Reports Positive Top-Line Results In Phase 3 InTandem3 Study For Sotagliflozin In Patients With Type 1 Diabetes

Sotagliflozin Demonstrates Statistically Significant Benefit in Primary Endpoint

First Week of January 2018 Options Trading For Lexicon Pharmaceuticals (LXRX)

Investors in Lexicon Pharmaceuticals, Inc. saw new options begin trading this week, for the January 2018 expiration.

Biotech Premarket Movers: Karyopharm, Lexicon, Prothena

Biotech Premarket Movers: Karyopharm, Lexicon, Prothena

Karyopharm Therapeutics falls 18%; Lexicon rises on drug approval.

Lexicon To Report Fourth Quarter And Year End 2016 Financial Results On March 3, 2017

Conference Call and Webcast to Follow

4 Smaller Biotech Names Worth Researching

4 Smaller Biotech Names Worth Researching

Here's why to check out Dynavax Technologies as well Lexicon, Supernus and Acadia Pharmaceuticals.

7 Things to Watch in Biotech Now

7 Things to Watch in Biotech Now

M&A, drug approvals and Trump are all on my watch list.

These 3 Biotech Stocks Are Already Moving Wildly on Thursday

These 3 Biotech Stocks Are Already Moving Wildly on Thursday

Here are some names that have caught our eye.

First Week of LXRX February 2017 Options Trading

First Week of LXRX February 2017 Options Trading

Investors in Lexicon Pharmaceuticals, Inc. saw new options begin trading this week, for the February 2017 expiration.

Notable Friday Option Activity: LXRX, WTW, XBIT

Notable Friday Option Activity: LXRX, WTW, XBIT

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Lexicon Pharmaceuticals, Inc. , where a total volume of 6,103 contracts has been traded thus far today, a contract volume which is representative of approximately 610,300 underlying shares (given that every 1 contract represents 100 underlying shares).

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AYR, CRCM, TG Downgrades: ADPT, AMZN, ANGI, ARNC, BKD, BWXT, CAJ, CALX, CSGP, EMR, HZO, LXRX, MNK, MYGN, NTRA, PBI, TCO, TRI Initiations: PFGC Read on to get TheStreet Quant Ratings' detailed report:

Short Interest In Lexicon Pharmaceuticals Moves 16% Higher

Short Interest In Lexicon Pharmaceuticals Moves 16% Higher

The most recent short interest data has been released for the 09/30/2016 settlement date, which shows a 2,011,299 share increase in total short interest for Lexicon Pharmaceuticals, Inc. , to 14,608,790, an increase of 15.97% since 09/15/2016.

First Week Of LXRX August 19th Options Trading

First Week Of LXRX August 19th Options Trading

Investors in Lexicon Pharmaceuticals, Inc. saw new options begin trading this week, for the August 19th expiration.

7 Stocks Spiking on Big Volume

7 Stocks Spiking on Big Volume

Here's a technical look at how to trade seven stocks rising on unusual volume.

Lexicon Pharmaceuticals (LXRX) Weak On High Volume Today

Lexicon Pharmaceuticals (LXRX) Weak On High Volume Today

Trade-Ideas LLC identified Lexicon Pharmaceuticals (LXRX) as a weak on high relative volume candidate

TheStreet Quant Rating: D (Sell)